Scarica l'app Stockscreener
4.80
20.60%
0.82
Pre-mercato:
4.93
0.13
+2.71%
Precedente Chiudi:
$3.98
Aprire:
$4.02
Volume 24 ore:
1.45M
Relative Volume:
4.12
Capitalizzazione di mercato:
$303.74M
Reddito:
$2.72M
Utile/perdita netta:
$-85.08M
Rapporto P/E:
-2.487
EPS:
-1.93
Flusso di cassa netto:
$-70.93M
1 W Prestazione:
+31.51%
1M Prestazione:
+54.84%
6M Prestazione:
+521.76%
1 anno Prestazione:
+277.95%
Intervallo 1D:
$4.01
$4.85
Intervallo di 1 settimana:
$3.5505
$4.85
Portata 52W:
$0.6922
$4.85
Shattuck Labs Inc Stock (STTK) Company Profile
Nome
Shattuck Labs Inc
Settore
Industria
Telefono
512-900-4690
Indirizzo
500 W. 5TH STREET, AUSTIN
Confronta STTK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
4.80 | 251.85M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-01 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | Iniziato | Wedbush | Outperform |
| 2025-03-17 | Iniziato | Leerink Partners | Outperform |
| 2024-10-02 | Downgrade | Citigroup | Buy → Neutral |
| 2024-10-02 | Downgrade | Needham | Buy → Hold |
| 2024-10-01 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-08-31 | Iniziato | BTIG Research | Buy |
| 2022-06-01 | Iniziato | Citigroup | Buy |
| 2022-05-02 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-14 | Iniziato | Berenberg | Buy |
| 2021-01-11 | Iniziato | Evercore ISI | Outperform |
| 2020-11-03 | Iniziato | Citigroup | Buy |
| 2020-11-03 | Iniziato | Cowen | Outperform |
| 2020-11-03 | Iniziato | Needham | Buy |
Mostra tutto
Shattuck Labs Inc Borsa (STTK) Ultime notizie
Shattuck Labs (NASDAQ:STTK) Trading 20.6% Higher – Time to Buy? - Defense World
Does Shattuck Labs Inc. stock trade at a discount to peersRisk Adjusted Returns & You’ve Never Seen Stock Picks Like These - ulpravda.ru
Why Madrigal Pharmaceuticals Stock Slumped on Tuesday - AOL.com
Shattuck Labs (STTK): Citigroup Maintains Neutral Rating, Raises Price Target | STTK Stock News - GuruFocus
Shattuck Labs (STTK) Stock Soars 74% Following Analyst Upgrade to Buy - Intellectia AI
Why Shattuck Labs Stock Soared in December - Yahoo Finance
Several Insiders Invested In Shattuck Labs Flagging Positive News - Yahoo Finance
Shattuck Labs (STTK) Price Target Increased by 15.61% to 2.72 - MSN
Shattuck Labs, Inc.'s (NASDAQ:STTK) biggest owners are retail investors who got richer after stock soared 10% last week - simplywall.st
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - AOL.com
Why Shattuck Labs Inc. stock is a must watch in 2025Portfolio Update Report & Daily Volume Surge Trade Alerts - Улправда
Can Shattuck Labs Inc. stock attract ESG capital inflowsEntry Point & Low Risk High Reward Trade Ideas - DonanımHaber
Will Shattuck Labs Inc. stock gain from lower inflationWeekly Stock Summary & Real-Time Market Sentiment Reports - DonanımHaber
How interest rate cuts could boost Shattuck Labs Inc. stockJuly 2025 Price Swings & Daily Price Action Insights - Улправда
How Shattuck Labs Inc. stock performs in rate cut cyclesMarket Activity Recap & Daily Profit Maximizing Trade Tips - Улправда
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Shattuck Labs, Inc. (NASDAQ:STTK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Shattuck Labs (NASDAQ:STTK) Shares Down 1.3%Time to Sell? - MarketBeat
Shattuck Labs (NASDAQ:STTK) Shares Down 1.3% – Time to Sell? - Defense World
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635 - Investing News Network
Shattuck Labs announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Shattuck Labs (NASDAQ: STTK) grants 206K inducement options under Rule 5635(c)(4) - Stock Titan
A History of Outperforming Analyst Forecasts and Beating the Odds: Shattuck Labs Inc (STTK) - setenews.com
Shattuck Labs (STTK) price target increased by 33.33% to 4.08 - MSN
Shattuck Labs (STTK) Price Target Increased by 33.33% to 4.08 - Nasdaq
What's Next For Shattuck Labs? SL-325 And Bispecific Antibody Programs - RTTNews
Why Shattuck Labs Inc. stock remains undervalued2025 Dividend Review & Weekly Top Performers Watchlists - Newser
STTK: Receptor-targeted TL1A therapy shows promise for safer, more effective treatment and rapid development - TradingView
Shattuck Labs, Inc. (STTK) Slides 8% in Pre-market: Without a Clear Catalyst - Stocks Telegraph
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? - AOL.com
It is Poised to be a Bull Market for Shattuck Labs Inc (STTK) - setenews.com
Why hedge funds are buying Shattuck Labs Inc. stockM&A Rumor & Stock Portfolio Risk Control - Newser
HC Wainwright & Co. Upgrades Shattuck Labs (STTK) - Nasdaq
Shattuck's Bowel Disease Treatment Looks Promising: AnalystShattuck Labs (NASDAQ:STTK) - Benzinga
Shattuck Labs Shares Rise After HC Wainwright Upgrade - marketscreener.com
STTK: Shattuck Labs Receives 'Buy' Upgrade from HC Wainwright & Co. | STTK Stock News - GuruFocus
Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright - Investing.com Canada
HC Wainwright Upgrades Shattuck Labs to Buy From Neutral, Price Target is $6 - marketscreener.com
Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Result - Yahoo Finance
Holdings of Shattuck Labs Inc (STTK) are aligned with the stars - Setenews
Hedge funds own 27% of Shattuck Labs, Inc. (NASDAQ:STTK) shares but individual investors control 32% of the company - Yahoo Finance
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Long term hold vs stop loss in Shattuck Labs Inc.2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Why Shattuck Labs Inc. stock could see breakout soonOil Prices & Community Supported Trade Ideas - newser.com
Should I hold or sell Shattuck Labs Inc. stock in 2025Trade Analysis Report & Expert-Curated Trade Recommendations - newser.com
Shattuck Labs to Participate in Upcoming December Investor Conferences - Investing News Network
Shattuck Labs (NASDAQ: STTK) to Join Piper Sandler and Evercore December Events - Stock Titan
Shattuck Labs Reports Improved Financial Performance - MSN
Will Shattuck Labs Inc. stock recover faster than marketWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com
Shattuck Labs Inc Azioni (STTK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
28.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):